- Press Releases
- Notices
Press Releases To List
-
- Aug.02.2021R & D
- Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy
-
- Jul.30.2021Management / Finance
- Announcement on Financial Results for FY2021 1Q
-
- Jul.19.2021R & D
- Phase 2 Clinical Study Initiated for Velexbru (tirabrutinib), a BTK Inhibitor, in Patients with Primary Central Nervous System Lymphoma in the US
Notices To List
About
We Want to Deliver New Drugs
to the World with a Wish.
For more than 300 years since its foundation in 1717, working for people’s health.
Diseases still unconquered. Patients' wishes still unfulfilled.
ONO, with a wish to meet these medical needs, devotes all its efforts to drug discovery.
